Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. [electronic resource]
- Journal of hepatology Jan 2012
- 137-45 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1600-0641
10.1016/j.jhep.2011.05.025 doi
Adamantane--analogs & derivatives Animals Cell Death--drug effects Enzyme Inhibitors--pharmacology Gene Knockdown Techniques Hepatocytes--drug effects In Vitro Techniques Inflammation--enzymology Liver--drug effects Lysophospholipids--metabolism Male Mice Mitochondria, Liver--drug effects Mitochondrial Membrane Transport Proteins--drug effects Mitochondrial Permeability Transition Pore Nitric Oxide Synthase Type II--metabolism Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors Pyridines--pharmacology RNA, Messenger--genetics RNA, Small Interfering--genetics Reperfusion Injury--drug therapy Sphingosine--analogs & derivatives